ストックスクリーナーアプリを入手
1.005
0.50%
-0.005
前日終値:
$1.01
開ける：
$1.02
24時間の取引高:
291.76K
Relative Volume:
0.15
時価総額：
$13.00M
収益：
-
当期純損益:
$-9.70M
株価収益率:
-0.9136
EPS:
-1.1
ネットキャッシュフロー:
$-8.57M
1週間 パフォーマンス:
-6.94%
1か月 パフォーマンス:
+5.28%
6か月 パフォーマンス:
-2.43%
1年 パフォーマンス:
-62.92%
1日の値動き範囲:
$0.97
$1.025
1週間の範囲:
$0.97
$1.13
52週間の値動き範囲:
$0.8099
$5.95
Marker Therapeutics Inc Stock (MRKR) Company Profile
名前
Marker Therapeutics Inc
セクター
電話
(713) 400-6400
住所
2450 HOLCOMBE BLVD, HOUSTON, TX
MRKR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.005 | 13.07M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.71 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.21 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Overweight |
| 2021-03-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 開始されました | ROTH Capital | Buy |
| 2019-03-01 | 開始されました | Janney | Buy |
| 2018-12-03 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Marker Therapeutics Inc (MRKR) 最新ニュース
Is this a good reentry point in Marker Therapeutics Inc.Market Trend Report & AI Driven Price Forecasts - newser.com
Developing predictive dashboards with Marker Therapeutics Inc. dataDip Buying & Reliable Entry Point Alerts - newser.com
Using R and stats models for Marker Therapeutics Inc. forecastingEarnings Recap Summary & Reliable Entry Point Trade Alerts - newser.com
Does Marker Therapeutics Inc. show high probability of reboundTrade Signal Summary & Expert Approved Momentum Ideas - newser.com
Tools to assess Marker Therapeutics Inc.’s risk profilePortfolio Return Summary & Accurate Entry/Exit Alerts - newser.com
What valuation multiples suggest for Marker Therapeutics Inc. stockPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Marker Therapeutics Inc. stock retracement – recovery analysisQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Volatility clustering patterns for Marker Therapeutics Inc.Dip Buying & Fast Gain Stock Tips - newser.com
Why retail investors pile into Marker Therapeutics Inc. stock2025 Top Gainers & High Win Rate Trade Tips - newser.com
Marker Therapeutics Inc. stock daily chart insightsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Real time breakdown of Marker Therapeutics Inc. stock performanceJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Best data tools to analyze Marker Therapeutics Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
What makes Marker Therapeutics Inc. (GX1) stock appealing to growth investorsJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program - Sahm
Marker Therapeutics Advances Off-the-Shelf T Cell Therapy with First Patient Treatment - TipRanks
Marker Therapeutics Launches Phase 1 RAPID Trial for Multi-Antigen Recognizing T Cells as Off-the-Shelf Treatment for AML and MDS - Quiver Quantitative
100x10^6‑cell initial dose: Marker Therapeutics treats first patient with MT‑401 in Phase 1 OTS RAPID study - Stock Titan
Marker Therapeutics Inc GX1 Stock Analysis and ForecastSwing Trading Watchlist & Exceptional Capital Trading - earlytimes.in
Is Marker Therapeutics Inc. trending in predictive chart models2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Will Marker Therapeutics Inc. stock maintain momentum in 2025Quarterly Portfolio Summary & Daily Entry Point Alerts - newser.com
How forex fluctuations impact Marker Therapeutics Inc. (GX1) stockMarket Risk Report & AI Enhanced Execution Alerts - newser.com
Will Marker Therapeutics Inc. (GX1) stock split increase liquidity2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Is Marker Therapeutics Inc. (GX1) stock worth holding before Fed meeting2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Is Marker Therapeutics Inc. (GX1) stock prepared for digital transition2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
Visualizing Marker Therapeutics Inc. stock with heatmapsJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Marker Therapeutics Inc (MRKR) 財務データ
収益
当期純利益
現金流量
EPS
Marker Therapeutics Inc (MRKR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| New Enterprise Associates 16, | 10% Owner |
Dec 23 '24 |
Buy |
3.20 |
554,250 |
1,773,600 |
1,625,678 |
1.19%
大文字化:
|
ボリューム (24 時間):